Top

European Archives of Oto-Rhino-Laryngology

Published in:

01-02-2018 | Laryngology

Voice outcome indicators for unilateral vocal fold paralysis surgery: a review of the literature

Authors: G. Desuter, M. Dedry, B. Schaar, J. van Lith-Bijl, P. P. van Benthem, E. V. Sjögren

Published in: European Archives of Oto-Rhino-Laryngology | Issue 2/2018

Abstract

Introduction

There is no consensus on which voice outcome indicators (VOIs) should be used to compare the merits of the various surgical treatments for unilateral vocal fold paralysis (UVFP). Authors performed a literature review to identify which VOIs are most frequently used and most relevant, in terms of significant change in pre- and post-operative measurements, to assess UVFP surgical treatments.

Method

A Medline/Pubmed literature review was performed and the most frequently used VOIs were identified using a Pareto diagram. For these most frequently used VOI’s, the number of studies that showed a statistically significant change in pre- and post-operative results were compared to the total number of studies found using that same VOI, this portion was expressed in percent. This percentage was defined as the “percentage of significance” and used to assess changes of each VOI.

Results

Eleven VOIs were identified using the Pareto analysis. These were, in decreasing order of frequency of citation: maximum phonation time (MPT), jitter, Shimmer, video-stroboscopic examination, noise to harmonic ratio (NHR/HNR), mean air flow (MeAF), fundamental frequency (F0), “Infrequent Perceptional Scales”, GRBAS scale, mean subglottic pressure (MSGP). MPT, MeAF, factor G of GRBAS-I, Jitter, shimmer and VHI-30 had respective “percentage of significance” of 90, 86, 85, 74, 68 and 64%, respectively.

Conclusion

The results indicate that MPT, MeAF and GRBAS-I, represent the top-three most frequently used and the most relevant VOIs in terms of “percentage of significance”. VHI-30 showed a relatively low rate of use and low “percentage of significance”. The role of Jitter and Shimmer remains unclear. Finally, MSGP and the F0 appear to be less relevant VOIs for the evaluation of UFVP surgical treatments in terms of significant change in pre- and post-operative measurements.

Abdel-Aziz MF, El-Hak NG, Carding PN (1998) Thyroplasty for functional rehabilitation of the incompetent larynx. J Laryngol Otol 112(12):1172–1175CrossRefPubMed

Adams SG, Irish JC, Durkin LC, Wong DL, Brown DH (1996) Evaluation of vocal function in unilateral vocal fold paralysis following thyroplastic surgery. J Otolaryngol 25(3):165–170PubMed

Alghonaim Y, Roskies M, Kost K, Young J (2013) Evaluating the timing of injection laryngoplasty for vocal fold paralysis in an attempt to avoid future type 1 thyroplasty. J Otolaryngol Head Neck Surg 42(1):1CrossRef

Almeida AAFD., Fernandes LR, Azevedo EHM, Pinheiro RSDA., Lopes LW (2015) Characteristics of voice and personality of patients with vocal fold immobility. CoDAS 27(2):178–185CrossRefPubMed

Asik MB, Karasimav O, Birkent H, Merati AL, Gerek M, Yildiz Y (2015) Airway and respiration parameters improve following vocal fold medialization a prospective study. Ann Otol Rhinol Laryngol 124(12):972–977CrossRefPubMed

Bielamowicz S, Berke GS, Gerratt BR (1995) A comparison of type I thyroplasty and arytenoid adduction. J Voice 9(4):466–472CrossRefPubMed

Billante CR, Clary J, Childs P, Netterville JL (2002) Voice gains following thyroplasty may improve over time1. Clin Otolaryngol Allied Sci 27(2):89–94CrossRefPubMed

Borel S, Crevier-Buchman L, Tessier C, Hans S, Laccourreye O, Brasnu D (2004) Quality of life before and after thyroplasty for vocal fold paralysis. Revue de laryngologie-otologie-rhinologie 125(5):287–290PubMed

Bryant NJ, Gracco LC, Sasaki CT, Vining E (1996) MRI evaluation of vocal fold paralysis before and after type I thyroplasty. Laryngoscope 106(11):1386–1392CrossRefPubMed

10.

Cantillo-Baños E, Jurado-Ramos A, Gutiérrez-Jódas J, Ariza-Vargas L (2013) Vocal fold insufficiency: medialization laryngoplasty vs calcium hydroxylapatite microspheres (Radiesse Voice®). Acta Oto-laryngol 133(3):270–275CrossRef

11.

Choi HS, Chung SM, Lim JY, Kim HS (2008) Increasing the closed quotient improves voice quality after type I thyroplasty in patients with unilateral vocal cord paralysis: analysis using SPEAD program. J Voice 22(6):751–755CrossRefPubMed

12.

Chowdhury K, Saha S, Saha VP, Pal S, Chatterjee I (2013) Pre and post operative voice analysis after medialization thyroplasty in cases of unilateral vocal fold paralysis. Indian J Otolaryngol Head Neck Surg 65(4):354–357CrossRefPubMedPubMedCentral

13.

Chhetri DK, Gerratt BR, Kreiman J, Berke GS (1999) Combined arytenoid adduction and laryngeal reinnervation in the treatment of vocal fold paralysis. Laryngoscope 109(12):1928–1936CrossRefPubMed

14.

Dastolfo C, Gartner-Schmidt J, Yu L, Carnes O, Gillespie AI (2015) Aerodynamic outcomes of four common voice disorders: moving toward disorder-specific assessment. J Voice 30(3):301–307CrossRefPubMed

15.

Desuter G, Henrard S, Boucquey D, Van Boven M, Gardiner Q, Remacle M (2015 Feb) Learning curve of medialization thyroplasty using a Montgomery™ implant. Eur Arch Otorhinolaryngol 272(2):385–390CrossRefPubMed

16.

Devos M, Schultz P, Guilleré F, Debry C (2010) Thyroplasty for unilateral vocal fold paralysis using an adjustable implant in porous titanium. Eur Ann Otorhinolaryngol Head Neck Dis 127(6):204–212CrossRefPubMed

17.

Elnashar I, El-Anwar M, Amer H, Quriba A (2015) Voice outcome after gore-tex medialization thyroplasty. Int Arch Otorhinolaryngol 19(3):248–254CrossRefPubMedPubMedCentral

18.

Gliklich RE, Glovsky RM, Montgomery WM (1999) Validation of a voice outcome survey for unilateral vocal cord paralysis. Otolaryngol Head Neck Surg 120(2):153–158CrossRefPubMed

19.

Gray SD, Barkmeier J, Jones D, Titze I, Druker D (1992) Vocal evaluation of thyroplastic surgery in the treatment of unilateral vocal fold paralysis. Laryngoscope 102(4):415–421CrossRefPubMed

20.

Guerrero J, Cobeta I, García-Díaz JD, Vegas A, Montojo J, Lorenzo F, Mate A (1998) Surgery of the laryngeal framework: type I thyroplasty. Acta Otorrinolaringol Esp 49(1):45–49PubMed

21.

Hajioff D, Rattenbury H, Carrie S, Carding P, Wilson J (2000) The effect of Isshiki type 1 thyroplasty on quality of life and vocal performance. Clin Otolaryngol Allied Sci 25(5):418–422CrossRefPubMed

22.

Harries ML, Morrison M (1995) Short-term results of laryngeal framework surgery–thyroplasty type 1: a pilot study. J Otolaryngol 24(5):281–287PubMed

23.

Havas TE, Priestley KJ (2003) Autologous fat injection laryngoplasty for unilateral vocal fold paralysis. ANZ J Surg 73(11):938–943CrossRefPubMed

24.

Hogikyan ND, Wodchis WP, Terrell JE, Bradford CR, Esclamado RM (2000) Voice-related quality of life (V-RQOL) following type I thyroplasty for unilateral vocal fold paralysis. J Voice 14(3):378–386CrossRefPubMed

25.

Jang JY, Lee G, Ahn J, Son YI (2015) Early voice rehabilitation with injection laryngoplasty in patients with unilateral vocal cord palsy after thyroidectomy. Eur Arch Otorhinolaryngol 272(12):3745–3750CrossRefPubMed

26.

Konomi U, Watanabe Y, Komazawa D (2014) Application of pitch range evaluation subsequent to arytenoid adduction and thyroplasty. J Voice 28(3):394–395CrossRefPubMed

27.

Kraus DH, Orlikoff RF, Rizk SS, Rosenberg DB (1999) Arytenoid adduction as an adjunct to type I thyroplasty for unilateral vocal cord paralysis. Head neck 21(1):52–59CrossRefPubMed

28.

Laccourreye O, Sharkawy E, Holsinger L, Hans FC, Ménard S, M., & Brasnu D (2005) Thyroplasty type I with montgomery implant among native French language speakers with unilateral laryngeal nerve paralysis. Laryngoscope 115(8):1411–1417CrossRefPubMed

29.

Leder SB, Sasaki CT (1994) Long-term changes in vocal quality following isshiki thyroplasty type I. Laryngoscope 104(3):275–277CrossRefPubMed

30.

Lee WT, Milstein C, Hicks D, Akst LM, Esclamado RM (2007) Results of ansa to recurrent laryngeal nerve reinnervation. Otolaryngol Head Neck Surg 136(3):450–454CrossRefPubMed

31.

Li AJ, Johns MM, Jackson-Menaldi C, Dailey S, Heman-Ackah Y, Merati A, Rubin AD (2011) Glottic closure patterns: type I thyroplasty versus type I thyroplasty with arytenoid adduction. J Voice 25(3):259–264CrossRefPubMed

32.

Lorenz RR, Esclamado RM, Teker AM, Strome M, Scharpf J, Hicks D, & Lee WT (2008) Ansa cervicalis-to-recurrent laryngeal nerve anastomosis for unilateral vocal fold paralysis: experience of a single institution. Ann Otol Rhinol Laryngol 117(1):40–45CrossRefPubMed

33.

Lu FL, Casiano RR, Lundy DS, Xue JW (1996) Longitudinal evaluation of vocal function after thyroplasty type I in the treatment of unilateral vocal paralysis. Laryngoscope 106(5):573–577CrossRefPubMed

34.

Lu FL, Lundy DS, Casiano RR, Xue JW (1998) Vocal evaluation of thyroplasty type I in the treatment of nonparalytic glottic incompetence. Ann Otol Rhinol Laryngol 107(2):113–119CrossRefPubMed

35.

Lundy DS, Casiano RR, Mc Clinton ME, & Xue JW (2003) Early results of transcutaneous injection laryngoplasty with micronized acellular dermis versus type-I thyroplasty for glottic incompetence dysphonia due to unilateral vocal fold paralysis. J Voice 17(4):589–595CrossRefPubMed

36.

Lundy DS, Casiano RR, Xue JW (2004) Can maximum phonation time predict voice outcome after thyroplasty type I? Laryngoscope 114(8):1447–1454CrossRefPubMed

37.

Lundy DS, Casiano RR, Xue JW, Lu FL (2000) Thyroplasty type I: short- versus long-term results. Otolaryngol Head Neck Surg 122(4):533–536PubMed

38.

Mahieu H, Norbart TH, Snel F (1996) Laryngeal framework surgery for voice improvement. Revue de laryngologie-otologie-rhinologie 117(3):189–197PubMed

39.

Malik A, Ramalingam WVBS., Nilakantan A, Nair S, Ramesh AV, Raj P (2014) Comparison of the use of silastic with titanium prefabricated implant in type I thyroplasty. Braz J Otorhinolaryngol 80(2):156–160CrossRefPubMed

40.

Manfredi C, Peretti G (2006) A new insight into postsurgical objective voice quality evaluation: application to thyroplastic medialization. IEEE Trans Biomed Eng 53(3):442–451CrossRefPubMed

41.

Matar N, Remacle M, Bachy V, Lawson G, Giovanni A, Lejoly-Devuyst V, Legou T (2012) Objective measurement of real time subglottic pressure during medialization thyroplasty: a feasibility study. Eur Arch Otorhinolaryngol 269(4):1171–1175CrossRefPubMed

42.

McLean-Muse A, Montgomery WW, Bunting G, Hillman RE, Doyle P, Varvares M, Eng J (2000) Montgomery® thyroplasty implant for vocal fold immobility: phonatory outcomes. Ann Otol Rhinol Laryngol 109(4):393–400CrossRefPubMed

43.

Mohammed H, Masterson L, Gendy S, Nassif R (2016) Outpatient based injection laryngoplasty for the management of unilateral vocal fold paralysis-clinical outcomes from a UK centre. Clin Otolaryngol 41(4):341–346CrossRefPubMed

44.

Morgan JE, Zraick RI, Griffin AW, Bowen TL, Johnson FL (2007) Injection versus medialization laryngoplasty for the treatment of unilateral vocal fold paralysis. Laryngoscope 117(11):2068–2074CrossRefPubMed

45.

Mortensen M, Carroll L, Woo P (2009) Arytenoid adduction with medialization laryngoplasty versus injection or medialization laryngoplasty: the role of the arytenoidopexy. Laryngoscope 119(4):827–831CrossRefPubMed

46.

Murata T, Yasuoka Y, Shimada T, Shino M, Iida H, Takahashi K, Furuya N (2011) A new and less invasive procedure for arytenoid adduction surgery. Laryngoscope 121(6):1274–1280CrossRefPubMed

47.

Nouwen J, Hans S, De Mones E, Brasnu D, Crevier-Buchman L, Laccourreye O (2004) Thyroplasty type I without arytenoid adduction in patients with unilateral laryngeal nerve paralysis: the Montgomery implant versus the Gore-Tex implant. Acta otolaryngol 124(6):732–738CrossRefPubMed

48.

Omori K, Slavit DH, Kacker A, Blaugrund SM (1996) Quantitative criteria for predicting thyroplasty type I outcome. Laryngoscope 106(6):689–693CrossRefPubMed

49.

Paniello RC, Edgar JD, Kallogjeri D, Piccirillo JF (2011) Medialization versus reinnervation for unilateral vocal fold paralysis: a multicenter randomized clinical trial. Laryngoscope 121(10):2172–2179CrossRefPubMedPubMedCentral

50.

Parker NP, Barbu AM, Hillman RE, Zeitels SM, Burnas JA (2015) Revision transcervical medialization laryngoplasty for unilateral vocal fold paralysis. Otolaryngol Head Neck Surg 153(4):593–598CrossRefPubMed

51.

Peretti G, Provenzano L, Piazza G, Giudice M, Antonelli AR (2001). Risultati funzionali dopo tiroplastica di I tipo con protesi di Montgomery. Acta Otorhinolaryngol Ital, 21, 156–161PubMed

52.

Prendes BL, Yung KC, Likhterov I, Schneider SL, Al-Jurf SA, Courey MS (2012) Long-term effects of injection laryngoplasty with a temporary agent on voice quality and vocal fold position. Laryngoscope 122(10):2227–2233CrossRefPubMed

53.

Ryu IS, Nam SY, Han MW, Choi SH, Kim SY, Roh JL (2012) Long-term voice outcomes after thyroplasty for unilateral vocal fold paralysis. Arch Otolaryngol Head Neck Surg 138(4):347–351CrossRefPubMed

54.

Sakai N, Nishizawa N, Matsushima JI, Kurihara H, Kokubun T, Koichi KI, … & Inuyama Y (1996) Thyroplasty type I with ceramic shim. Artif Organs 20(8):951–954CrossRefPubMed

55.

Sasaki CT, Leder SB, Petcu L, Friedman CD (1990). Longitudinal voice quality changes following Isshiki thyroplasty type I: the Yale experience. Laryngoscope 100(8), 849–852CrossRefPubMed

56.

Schwarz K, Cielo CA, Steffen N, Becker J, Jotz GP (2011) Voice and laryngeal configuration of men with unilateral vocal fold paralysis before and after medialization. J Voice 25(5):611–618PubMed

57.

Shin JE, Nam SY, Yoo SJ, Kim SY (2002) Analysis of voice and quantitative measurement of glottal gap after thyroplasty type I in the treatment of unilateral vocal paralysis. J Voice 16(1):136–142CrossRefPubMed

58.

Smith ME, Houtz DR (2016) Outcomes of laryngeal reinnervation for unilateral vocal fold paralysis in children: associations with age and time since injury. Ann Otol Rhinol Laryngol 125(5):433–438CrossRefPubMed

59.

Sonoda S, Kataoka H, Inoue T (2005) Traction of lateral cricoarytenoid muscle for unilateral vocal fold paralysis: comparison with Isshiki’s original technique of arytenoid adduction. Ann Otol Rhinol Laryngol 114(2):132–138CrossRefPubMed

60.

Sridhara SR, Ashok KG, Raghunathan M, Mann SBS (2003) To study voice quality before and after thyroplasty type 1 in patients with symptomatic unilateral vocal cord paralysis. Am J Otolaryngol 24(6):361–365CrossRefPubMed

61.

Stuut M, Gi RETP., Dikkers FG (2014) Change of voice handicap index after treatment of benign laryngeal disorders. Eur Arch Otorhinolaryngol 271(5):1157–1162CrossRefPubMed

62.

Suehiro A, Hirano S, Kishimoto Y, Tanaka S, Ford CN (2009). Comparative study of vocal outcomes with silicone versus Gore-Tex thyroplasty. Ann Otol Rhinol Laryngol 118(6):405–408

63.

Thompson DM, Maragos NE, Edwards BW (1995) The study of vocal fold vibratory patterns in patients with unilateral vocal fold paralysis before and after type I thyroplasty with or without arytenoid adduction. Laryngoscope 105(5):481–486CrossRefPubMed

64.

Tokashiki R, Hiramatsu H, Shinada E, Motohashi R, Nomoto M, Toyomura F, Suzuki M (2012) Analysis of pitch range after arytenoid adduction by fenestration approach combined with type I thyroplasty for unilateral vocal fold paralysis. J Voice 26(6):792–796CrossRefPubMed

65.

Tokashiki R, Hiramatsu H, Tsukahara K, Kanebayashi H, Nakamura M, Motohashi R, Yamada T, Suzuki M (2007) A “fenestration approach” for arytenoid adduction through the thyroid ala combined with type I thyroplasty. Laryngoscope 117(10):1882–1887CrossRefPubMed

66.

Tucker HM (1999) Long-term preservation of voice improvement following surgical medialization and reinnervation for unilateral vocal fold paralysis. J Voice 13(2):251–256CrossRefPubMed

67.

Umeno H, Chitose S, Sato K, Nakashima T (2009) Comparative study of framework surgery and fat injection laryngoplasty. J Laryngol Otol 123(S31):35–41CrossRef

68.

Umeno H, Chitose SI, Sato K, Nakashima T (2008) Efficacy of additional injection laryngoplasty after framework surgery. Ann Otol Rhinol Laryngol 117(1):5–10CrossRefPubMed

69.

Umeno H, Chitose SI, Sato K, Ueda Y, Nakashima T (2012) Long-term postoperative vocal function after thyroplasty type I and fat injection laryngoplasty. Ann Otol Rhinol Laryngol 121(3):185–191CrossRefPubMed

70.

Vinson KN, Zraick RI, Ragland FJ (2010). Injection versus medialization laryngoplasty for the treatment of unilateral vocal fold paralysis. Laryngoscope 120(9):1802–1807.CrossRefPubMed

71.

Wen MH, Cheng PW, Liao LJ, Chou HW, Wang CT (2013) Treatment outcomes of injection laryngoplasty using cross-linked porcine collagen and hyaluronic acid. Otolaryngol Head Neck Surg. https://doi.org/10.1177/0194599813508082.PubMed

72.

Zur KB, Carroll LM (2015) Recurrent laryngeal nerve reinnervation in children: acoustic and endoscopic characteristics pre-intervention and post-intervention. A comparison of treatment options. Laryngoscope 125(S11):S1-S15

73.

Jacobson BH, Johnson A, Silbergeit GrywalskiC, Jocobson A, Benninger G, Newman MS; C.W (1997))The voice handicap index (VHI): development and validation. Am J Speech Lang Pathol 6:66–70CrossRef

74.

Siu J, Tam S, Fung K (2016) A comparison of outcomes in interventions for unilateral vocal fold paralysis: a systematic review. Laryngoscope 126(7):1616–1624CrossRefPubMed

75.

Dejonckere PH, Bradley P, Clemente P, Cornut G, Crevier-Buchman L, FriedrichG, Van De Heyning P, Remacle M, Woisard V; Committee on Phoniatrics of the European Laryngological Society (ELS) (2001) A basic protocol for functional assessment of voice pathology, especially for investigating the efficacy of (phonosurgical) treatments and evaluating new assessment techniques. Guideline elaborated by the Committee on Phoniatrics of the European Laryngological Society (ELS). Eur Arch Otorhinolaryngol 258(2):77–82CrossRefPubMed

76.

Rosen CA, Mau T, Remacle M, Hess M, Eckel HE, Young VN, Hantzakos A, Yung KC, Dikkers FG (2016) Nomenclature proposal to describe vocal fold motion impairment. Eur Arch Otorhinolaryngol 273(8):1995–1999CrossRefPubMed

77.

Young VN, Zullo TG, Rosen CA (2010) Analysis of laryngeal framework surgery: 10-year follow-up to a national survey. Laryngoscope 120(8):1602–1608CrossRefPubMed

78.

Dastolfo C, Gartner-Schmidt J, Yu L, Carnes O, Gillespie AI (2016) Aerodynamic outcomes of four common voice disorders: moving toward disorder-specific assessment. J Voice 30(3):301–307CrossRefPubMed

79.

Woo P, Casper J, Colton R, Brewer D (1994) Aerodynamic and stroboscopic findings before and after microlaryngeal surgery. J Voice 8(2):186–194

80.

Webb AL, Carding PN, Deary IJ, MacKenzie K, Steen N, Wilson JA (2004) The reliability of three perceptual evaluation scales for dysphonia. Eur Arch Otorhinolaryngol 261(8):429–434CrossRefPubMed

81.

Ghio A, Revis J, Merienne S, Giovanni A (2013) Top-down mechanisms in dysphonia perception: the need for blind tests. J Voice 27(4):481–485CrossRefPubMed

Title: Voice outcome indicators for unilateral vocal fold paralysis surgery: a review of the literature
Authors: G. Desuter
M. Dedry
B. Schaar
J. van Lith-Bijl
P. P. van Benthem
E. V. Sjögren
Publication date: 01-02-2018
Publisher: Springer Berlin Heidelberg
Published in: European Archives of Oto-Rhino-Laryngology / Issue 2/2018
Print ISSN: 0937-4477
Electronic ISSN: 1434-4726
DOI: https://doi.org/10.1007/s00405-017-4844-9

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Voice outcome indicators for unilateral vocal fold paralysis surgery: a review of the literature

Abstract

Introduction

Method

Results

Conclusion

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Introduction

Method

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 2/2018

Are neutrophil, platelet and eosinophil-to-lymphocyte ratio and red blood cell distribution width can be used for nasal polyposis?

Safety of intranasal corticosteroid sprays during pregnancy: an updated review

Risk factors for intraoperative bradycardia during ear, nose, throat and maxillofacial surgery

Minimally invasive endoscopic transcanal cartilage myringoplasty is the treatment of choice for repair of anterosuperior perforations

The outcome of cochlear implantation among children with genetic syndromes

Comment on “The effect of septoplasty surgery on serum oxidative stress levels”